Bioinformatics brings to light new combinations of drugs to fight breast cancer
Combined therapy using two drugs emerges as a promising approach to tackle cancer resistance. Biocomputational analyses at IRB help to detect new synergistic combinations, such as raloxifene and cabozantinib, for the treatment of breast cancer.
from Biotech News
0 Comments